PRASUGREL News
PRASUGREL currently has 2 news articles, with 11 predicted indications.
This page combines the AI-predicted indications for PRASUGREL with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (11):
- acute coronary syndrome (99.0%)
- pulmonary hypertension (99.9%)
- migraine disorder (99.9%)
- migraine with brainstem aura (99.8%)
- kyphoscoliotic heart disease (99.8%)
- rheumatoid arthritis (99.7%)
- homozygous familial hypercholesterolemia (99.7%)
- hypoalphalipoproteinemia (99.7%)
- migraine with or without aura, susceptibility to (99.7%)
- brachydactyly-syndactyly syndrome (99.6%)
- leprosy (99.5%)
Related News (2)
From wrist to research: Harnessing smartwatch data for equitable cardiovascular research
2026-09-28 cardiovascular
Source: journals.plos.org
Conference MDAngle: HFSA 2026 Amyloidosis/ATTR-CM
2026-09-28 heart disease
Source: Medscape
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.